chr10-87960913-G-A
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000314.8(PTEN):c.821G>A(p.Trp274*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000314.8 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Cowden syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- PTEN hamartoma tumor syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- macrocephaly-autism syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- leiomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- activated PI3K-delta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Bannayan-Riley-Ruvalcaba syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lhermitte-Duclos diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Proteus-like syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- glioma susceptibility 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PTEN | NM_000314.8 | c.821G>A | p.Trp274* | stop_gained | Exon 8 of 9 | ENST00000371953.8 | NP_000305.3 | |
| PTEN | NM_001304717.5 | c.1340G>A | p.Trp447* | stop_gained | Exon 9 of 10 | NP_001291646.4 | ||
| PTEN | NM_001304718.2 | c.230G>A | p.Trp77* | stop_gained | Exon 8 of 9 | NP_001291647.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PTEN | ENST00000371953.8 | c.821G>A | p.Trp274* | stop_gained | Exon 8 of 9 | 1 | NM_000314.8 | ENSP00000361021.3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 36
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
PTEN-related disorder Pathogenic:1
The PTEN c.821G>A variant is predicted to result in premature protein termination (p.Trp274*). This variant was apparently detected and de novo in an individual with PTEN-related phenotypes (Busa et al 2015. PubMed ID: 25549896, reported with a protein nomenclature error, NM_000314:c.821G>A, p.Thr274X). This variant has not been reported in a large population database, indicating it is rare. Nonsense variants in PTEN, are expected to be pathogenic, and several have been associated with disease immediately up- and downstream of this variant position. This variant is interpreted as pathogenic.
PTEN hamartoma tumor syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Trp274*) in the PTEN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PTEN are known to be pathogenic (PMID: 9467011, 21194675). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with PTEN hamartoma tumor syndrome (PMID: 21659347, 25549896). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 1762511). For these reasons, this variant has been classified as Pathogenic.
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.W274* pathogenic mutation (also known as c.821G>A), located in coding exon 8 of the PTEN gene, results from a G to A substitution at nucleotide position 821. This changes the amino acid from a tryptophan to a stop codon within coding exon 8. This mutation reportedly occurred de novo in a patient diagnosed in early childhood with developmental delay, motor and speech delay, macrocephaly, and abnormal brain MRI (Busa T et al. Eur. J. Paediatr. Neurol. 2015 Mar;19:188-92). This mutation was also reported in an individual with features of PTEN hamartoma tumor syndrome (Pilarski R et al. J. Med. Genet. 2011 Aug;48:505-12) including macrocephaly, skin papules, a neurofibroma, a mucosal neuroma, and cafe au lait spots at age 13 (Pilarski R, personal communication). Of note, this alteration is also designated as p.Thr274X in published literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at